You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
金活醫藥集團(01110.HK)與廣東中聯建建築工程訂立建設工程協議
格隆匯 06-25 22:26

格隆匯6月25日丨金活醫藥集團(01110.HK)公吿,於2021年6月25日,龍德健康(由深圳金活(為公司全資子公司)及深圳上橫崗分別擁有90%及10%權益的合營企業)與承包商廣東中聯建建築工程有限公司就在地塊上進行建設工程訂立該協議,代價為人民幣1.36億元。

"地塊"指位於中國深圳市龍崗區寶龍工業區的地塊,其面積約9,999.7平方米,作工業用途。

集團將充分整合各項資源,把該地塊上的龍德健康產業園打造成特色的四大核心板塊,包括(1)中醫藥研發中心,將用於與粵港高校、科技機構建立多點試驗室;(2)"深圳市健康產業科技創新中心",聯合建設規劃打造健康項目孵化平台;(3)在園區內建立深港河套地區建設的中醫藥科技創新園配套的 地發展中心;及(4)在深圳建立 集團全國物流及分銷中心以及主要物流企業。 集團致力於打造全渠道全鏈條醫藥供應鏈。

 集團相信,分銷中心竣工將為 集團搭建更完善、更便捷的全國物流系統提供有力支持,進一步提升集團在物流行業的綜合實力,為深圳市以至全國的物流企業發展起到積極的示範作用。 集團相信,龍德健康產業園的建設及運營將有助於 集團佈局研、產、銷一體化運作,在新時期打造新的核心競爭力,並符合 公司及股東整體利益。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account